Inventor · disambiguated record
William H. Hildebrand
Also filed as: HILDEBRAND WILLIAM · HILDEBRAND WILLIAM H
6 granted patents·42 pending applications·32 citations·filing 1998–2023
76Inventor score
Top patents by PatentIndex Score
48 records- 0176US7521202B2Method and apparatus for the production of soluble MHC antigens and uses thereofUNIV OKLAHOMA·Filed 2005·Granted Apr 21, 2009·3 cites·12 claims
- 0271US2024041994A1Cmv vaccine and method of making and using the sameUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 0371US2023059301A1Identification of mhc class i phospho-peptide antigens from breast cancer utilizing shla technology and complementary enrichment strategiesAGENUS INC·Filed 2022·Application pending·0 cites
- 0463US7541429B2Comparative ligand mapping from MHC positive cellsUNIV OKLAHOMA·Filed 2001·Granted Jun 2, 2009·2 cites·15 claims
- 0563US2015094213A1Comparative Ligand Mapping from MHC Positive CellsUNIV OKLAHOMA·Filed 2014·Application pending·0 cites
- 0663US2021163572A1Soluble HLA class II complexes and methods of production and uses thereofUNIV OKLAHOMA·Filed 2020·Application pending·0 cites
- 0760US6287764B1Class I sequence based typing of HLA-A, -B, and -C alleles by direct DNA sequencingFiled 1998·Granted Sep 11, 2001·27 cites·4 claims
- 0860US2022211828A1Target peptides for ovarian cancer therapy and diagnosticsUNIV VIRGINIA PATENT FOUNDATION·Filed 2021·Application pending·0 cites
- 0959US2018306805A1Comparative ligand mapping from mhc class i positive cellsUNIV OKLAHOMA·Filed 2018·Application pending·0 cites
- 1059US2016000893A1Target peptides for ovarian cancer therapy and diagnosticsUniv Virginia Patent Found·Filed 2013·Application pending·0 cites
- 1157US2020171135A1CMV Vaccine and Method of Making and Using the SameUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 1255US2013143235A1Comparative ligand mapping from mhc class i positive cellsUNIVERSIT BOARD OF REGENTS·Filed 2012·Application pending·0 cites
- 1355US2004110192A1Class I sequence based typing of HLA-A, -B, and -C alleles by direct DNA sequencingFiled 2003·Application pending·0 cites
- 1454US2009226474A1Antibodies as T cell receptor mimics, methods of production and uses thereofWEIDANZ JON A·Filed 2008·Application pending·0 cites
- 1552US2007128629A1Class I sequence based typing of HLA-A, -B, and -C alleles by direct DNA sequencingHILDEBRAND WILLIAM H·Filed 2006·Application pending·0 cites
- 1651US2005009104A1Methods of attaching soluble HLA to solid supportsFiled 2004·Application pending·0 cites
- 1749US2010003718A1Method and apparatus for the production of soluble mhc antigens and uses thereofHILDEBRAND WILLIAM H·Filed 2009·Application pending·0 cites
- 1849US2004126829A1Anti-HLA assay and methodsFiled 2003·Application pending·0 cites
- 1949US2008145872A1Expression of HLA proteins on non human cellsHILDEBRAND WILLIAM H·Filed 2008·Application pending·0 cites
- 2049US2013237689A1Soluble hla class ii complexes and methods of production and use thereofHILDEBRAND WILLIAM H·Filed 2013·Application pending·0 cites
- 2149US2009062512A1Comparative ligand mapping from MHC class I positive cellsHILDEBRAND WILLIAM H·Filed 2008·Application pending·0 cites
- 2249US2005003483A1Comparative ligand mapping from MHC class 1 positive cellsFiled 2004·Application pending·0 cites
- 2348US2003017458A1Class I sequence based typing of HLA-A, -B, and -C alleles by direct DNA sequencingFiled 2001·Application pending·0 cites
- 2447US2009182131A1Methods for removing anti-MHC antibodies from a sampleHILDEBRAND WILLIAM H·Filed 2007·Application pending·0 cites
- 2547US2011288270A1Comparative ligand mapping from mhc class i positive cellsHILDEBRAND WILLIAM H·Filed 2011·Application pending·0 cites
- 2645US2012301871A1Comparative ligand mapping from mhc positive cellsHILDEBRAND WILLIAM H·Filed 2010·Application pending·0 cites
- 2745US2012302452A1Comparative ligand mapping from mhc class i positive cellsHILDEBRAND WILLIAM H·Filed 2010·Application pending·0 cites
- 2844US2006034865A1Soluble MHC artificial antigen presenting cellsHILDEBRAND WILLIAM H·Filed 2005·Application pending·0 cites
- 2944US2010105107A1Purification and characterization of soluble mhc proteinsHILDEBRAND WILLIAM H·Filed 2009·Application pending·0 cites
- 3043US2007065860A1Accelerated class I and class II HLA DNA sequence-based typingHILDEBRAND WILLIAM H·Filed 2006·Application pending·0 cites
- 3143US2012329080A1Anti-hla assay and methodsHILDEBRAND WILLIAM H·Filed 2012·Application pending·0 cites
- 3243US2012329670A1Epitope testing using soluble hlaHILDEBRAND WILLIAM H·Filed 2012·Application pending·0 cites
- 3343US2003124613A1Epitope testing using soluble HLAFiled 2002·Application pending·0 cites
- 3442US2006040310A1Epitope testing using soluble HLAHILDEBRAND WILLIAM H·Filed 2005·Application pending·0 cites
- 3541US2002122820A1Soluble MHC artificial antigen presenting cellsFiled 2002·Application pending·0 cites
- 3640US2013131573A1Selective anti-hla antibody removal device and methods of production and use thereofHILDEBRAND WILLIAM H·Filed 2012·Application pending·0 cites
- 3739US2011065587A1Epitope testing using soluble hlaHILDEBRAND WILLIAM H·Filed 2010·Application pending·0 cites
- 3838US10457682B2Small molecules that bind MR1UNIV OREGON HEALTH & SCIENCE·Filed 2017·Granted Oct 29, 2019·0 cites·7 claims
- 3937US2006035338A1Method and apparatus for the production of soluble MHC antigens and uses thereofPURE PROTEIN LLC·Filed 2005·Application pending·0 cites
- 4037US2003166057A1Method and apparatus for the production of soluble MHC antigens and uses thereofFiled 2001·Application pending·0 cites
- 4136US9110080B2Epitope testing using soluble HLAHILDEBRAND WILLIAM H·Filed 2011·Granted Aug 18, 2015·0 cites·12 claims
- 4236US2002156773A1Soluble HLA ligand database utilizing predictive algorithms and methods of making and using sameFiled 2002·Application pending·0 cites
- 4335US2007026433A1Epitope testing using soluble HLAHILDEBRAND WILLIAM H·Filed 2006·Application pending·0 cites
- 4433US2018319863A1Anti-hla assay and methodsUNIV OKLAHOMA·Filed 2018·Application pending·0 cites
- 4530US10857219B2Compositions comprising soluble HLA/M. tuberculosis-specific ligand complexes and methods of production and use thereofUNIV OKLAHOMA·Filed 2015·Granted Dec 8, 2020·0 cites·6 claims
- 4630US2006276629A9Purification and characterization of soluble human HLA proteinsHILDEBRAND WILLIAM H·Filed 2003·Application pending·0 cites
- 4729US2013245385A1Selective anti-hla antibody removal device and methods of production and use thereofHILDEBRAND WILLIAM H·Filed 2013·Application pending·0 cites
- 4829US2007099182A1Comparative ligand mapping from MHC class I positive cellsHILDEBRAND WILLIAM H·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William H. Hildebrand files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →